Ticker archive · $KRYS

$KRYS Filing Signals & Market Reactions

Delayed, SEO-crawlable recaps of AI-scored catalysts for $KRYS — including observed post-filing price moves. Live streaming stays exclusive to VIP.

? All delayed signals

$KRYS

$KRYS – Krystal Biotech Q3 Revenue Up 30% to $127.3M, Authorizes $400M Buyback

Krystal Biotech, Inc.

2026-11-02 00:00:00 UTC · SEC_8K · All $KRYS

?? Positive AI Sentiment (+3.0 / 10)

Q3 product revenue rose to $127.3M vs $97.8M in Q3 2025.
Diluted EPS dropped to $2.05 from $2.66 primarily due to non-operating expenses.
Cash reserves reached $1.2B and Board authorized up to $400M in share repurchases.

Unlock Live VIP Terminal & Telegram – €10/mo Original filing ?